Cut through the noise.
Trade on the signal.

A weekly synthesis of institutional-grade financial reports and market mechanics.

No spam. Unsubscribe anytime.

All Reports / Market Intelligence

Latest Reports

12 of 251 reports
DEZ.DE —
—
Deutz AG

Deutz (DEZ.DE): Hidden Minority Ownership – NINGI Research

NINGI Research alleges Deutz hid FFG Industries' 45% minority owner, overstating revenue, EBITDA, cash and leverage in its takeover case. Our take inside.

MOON.V —
—
Blue Moon Metals

Blue Moon Metals (MOON.V): Russia Ties and Halt – Viceroy Research

Viceroy Research alleges Blue Moon's Nussir sale could be delayed or derailed by buyer ACG's Russia ties, risking a cash crunch and mine care.

GRGD.TO —
—
Groupe Dynamite Inc.

Groupe Dynamite (GRGD.TO): Unsustainable Surge – Spruce Point Capital Management

Spruce Point Capital Management alleges Groupe Dynamite's surge is unsustainable, with reporting red flags, cash outflows, and 35%-70% downside risk.

NVDA —
—
Nvidia Corporation

NVIDIA (NVDA): Photo Identity Question – Muddy Waters

Muddy Waters alleges a woman photographed with former NVIDIA sales chief Ajay Puri may be ex-SMCI executive Cenly Chen, tied to China-sales claims.

NCPL —
—
Netcapital Inc.

Netcapital (NCPL): Sham Revenue Scheme – Fugazi Research

Fugazi Research says the SEC alleges Netcapital booked $13.9M in sham revenue, with backdated deals, a resigned auditor and heavy dilution.

EMAT —
—
Evolution Metals & Technologies Corp.

Evolution Metals & Technologies (EMAT): Whistleblower Payoff – Capybara Research

Capybara Research alleges Evolution Metals executives discussed a $2 million whistleblower payoff to hide a Korean operations matter from auditors and.

AMBQ —
—
Ambiq Micro

Ambiq Micro (AMBQ): No Profit Path – J Capital Research

J Capital Research says Ambiq Micro has no path to profit, citing losses, customer concentration, insider selling and dilution after two share issues.

LYCA —
—
Lycia Therapeutics

Lycia Therapeutics (LYCA): Valuation Under Pressure – Two Natural Capital

Two Natural Capital alleges Lycia's allergy drug trails Excellergy's stronger primate data, making LYCA hard to value unless the rival stumbles.

CYPH —
—
Cypherpunk Technologies Inc.

Cypherpunk Technologies (CYPH): Warrant Overhang – Fugazi Research

Fugazi Research alleges Cypherpunk's warrant overhang, related-party custody and Winklevoss ties leave shareholders facing heavy dilution and loss.

NVDA —
—
Nvidia Corporation

NVIDIA (NVDA): OpenAI Rent Backstop – Hunterbrook Media

Hunterbrook Media says Nvidia faces $530.5 billion in AI commitments, including a $105 billion OpenAI rent backstop tied to Ohio campus risk.

TWST —
—
Twist Bioscience

Problems at Twist Bioscience (TWST) – HUNTERBROOK

Hunterbrook says Twist Bioscience's TWST rally to $200 may have overshot amid AI-fueled enthusiasm, competition, and valuation risk.

ARLO —
—
Arlo Technologies, Inc.

Arlo Technologies – Board Letter – October 29, 2026 – Snowcap

Snowcap says 72% of Arlo paid accounts are low-profit partnerships, masking weaker retail subscription economics.